Drugmaker AbbVie sued the state in June because of Senate Bill 71, which forbade drug companies from limiting how many ...
Court rejects AbbVie 340B restrictions, upholding Colorado law protecting contract pharmacies under the 340B Drug Pricing Program.
Q3 2025 Earnings Call Transcript November 6, 2025 Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $0 ...
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q3 CY2025 results exceeding the market’s revenue ...
Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...
The FDA on Thursday awarded six new Commissioner’s National Priority Vouchers for a variety of conditions including lung cancer, rectal cancer and weight loss.
Congress has handed hospital giants a new line of taxpayer-funded credit. This summer, Congress included a $50 billion “rural health fund” in the multitrillion-dollar One Big Beautiful ...
On October 30, 2025, the Office of Pharmacy Affairs (OPA) posted information on its website announcing that they have approved 340B rebate models applicable to eight drug manufacturers. Consistent ...
On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...
That is why we strongly support House Bill 276 and Senate Bill 198, which aim to protect patient access to affordable ...
Transitioning from CFO to CEO required a major mindset shift from managing numbers to inspiring people, Wells says. Drawing on his operational finance background, he describes adopting more of a “head ...
Get key takeaways from Lantheus’ Q3 2025 earnings call: leadership changes, PYLARIFY stabilization, Neuraceq growth, and a 2026 product launch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback